Atabak Mokari
2020 - BELLICUM PHARMACEUTICALS
In 2020, Atabak Mokari earned a total compensation of $1.7M as Former Chief Financial Officer at BELLICUM PHARMACEUTICALS, a 49% increase compared to previous year.
Compensation breakdown
Option Awards | $542,889 |
---|---|
Salary | $408,373 |
Stock Awards | $163,764 |
Other | $536,708 |
Total | $1,651,734 |
Mokari received $542.9K in option awards, accounting for 33% of the total pay in 2020.
Mokari also received $408.4K in salary, $163.8K in stock awards and $536.7K in other compensation.
Rankings
In 2020, Atabak Mokari's compensation ranked 6,408th out of 13,090 executives tracked by ExecPay. In other words, Mokari earned more than 51.0% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 6,408 | 51st |
Manufacturing | 2,645 | 53rd |
Chemicals And Allied Products | 1,067 | 53rd |
Drugs | 922 | 53rd |
Pharmaceutical Preparations | 690 | 53rd |
Mokari's colleagues
We found two more compensation records of executives who worked with Atabak Mokari at BELLICUM PHARMACEUTICALS in 2020.